Second-trimester TOP : a Retrospective Study Comparing Complications at 12-14 vs 14-16 Weeks of Gestation
Second-trimester Termination of Pregnancy: A Retrospective Study Comparing Complications Related to Termination of Pregnancy at 12-14 Weeks' Gestation Versus 14-16 Weeks' Gestation
1 other identifier
observational
122
0 countries
N/A
Brief Summary
In France, the recently adopted law relating to the legal time limit for access to voluntary interruption of pregnancy has set a threshold of the term at which it can be performed up to 16 weeks of gestation. This single-centre study conduced at the Nancy Maternity Hospital is based on a retrospective cohort of all patients who underwent a medical termination of pregnancy between January 2010 and October 2021. The main objective is to evaluate the complications according to the term of the termination of pregnancy between two groups : \[12-14\] vs \[14-16\] weeks of gestation. The secondary objective is the distribution of these complications between the two groups. Pregnancy termination can be performed in two methods, either by medical method with mifepristone and misoprostol, or by surgical method by dilation and evacuation. Complications identified are haemorrhage, infection, retained product of trophoblast, uterine rupture and abortion induction failure. The hypothesis is the concomitant increase in complications with the term of the termination of pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2010
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedFirst Submitted
Initial submission to the registry
July 11, 2022
CompletedFirst Posted
Study publicly available on registry
July 21, 2022
CompletedJuly 21, 2022
July 1, 2022
Same day
July 11, 2022
July 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
complications
hemorrhage, infection, retained product of conception, failure, uterine rupture
Day 0
Secondary Outcomes (1)
repartition of all complications
Day 0
Study Arms (2)
Termination of pregnancy between 12-14 weeks of gestation
Termination of pregnancy between 14-16 weeks of gestation
Eligibility Criteria
women of childbearing age, major, with a single pregnancy who underwent for termination of pregnancy for medical reasons (maternal or foetal) between 12 and 16 weeks of gestation.
You may qualify if:
- termination of pregnancy for a medical reason
- between 12 and 16 weeks of gestation
- singleton pregnancy
You may not qualify if:
- multiple pregnancy
- abortion occurred before the induction of termination of pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist assistant in gynaecology and obstetrics
Study Record Dates
First Submitted
July 11, 2022
First Posted
July 21, 2022
Study Start
January 1, 2010
Primary Completion
January 1, 2010
Study Completion
October 1, 2021
Last Updated
July 21, 2022
Record last verified: 2022-07